ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1655

Aberrant Noncoding RNAs Are Enriched in Extracellular Vesicles and Implicated in Interferon Activation

Sandra Williams1, Soyeong Sim2 and Sandra Wolin2, 1National Institute of Arthritis, Musculoskeletal and Skin Diseases; National Cancer Institute, Bethesda, MD, 2National Cancer Institute, Frederick, MD

Meeting: ACR Convergence 2025

Keywords: Cell Trafficking Angiogenesis, Cell-signalling molecules, interferon, Non-coding RNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: Cytokines & Cell Trafficking (1650–1655)

Session Type: Abstract Session

Session Time: 2:15PM-2:30PM

Background/Purpose: Extracellular vesicles (EVs) are small structures that enclose a variety of nucleic acids. While much of the published work on EV RNA has focused on the role of mRNAs and microRNAs in intercellular communication, these RNAs are a small fraction of the RNA cargoes of EVs (1). RNA surveillance pathways eliminate defective RNAs and are also implicated in maintaining immunological tolerance to host RNA (2). We hypothesized that EVs package defective noncoding RNAs (ncRNAs) as part of a novel RNA surveillance pathway, which may prevent these RNAs from being recognized as foreign and activating an interferon response.

Methods: We generated mouse macrophage RAW 264.7 cell lines that stably express doxycycline-inducible shRNAs against Dis3l2 as well as control nonsilencing shRNAs. Dis3l2 is a ribonuclease that degrades aberrant structured ncRNAs in cytosol. We purified EVs from these cell lines and used a thermostable group II intron reverse transcriptase to make cDNA libraries and sequence RNA from whole cells and EVs, which allowed us to characterize highly structured RNAs that are missed by conventional RNA-Seq. We also performed conventional RNA-Seq on Dis3l2-depleted cells. To determine effects of preventing exosome packaging, we treated RAW 264.7 cells with pharmacological EV inhibitors and performed Northern blots and qPCR on cellular RNA after drug treatment.

Results: Across multiple classes of RNAs, including small ncRNAs, repeat RNAs, mRNAs, and microRNAs, EVs are enriched for aberrant transcripts. Many aberrant transcripts are further enriched in EVs purified from cells depleted of Dis3l2. We confirmed our sequencing results with Northern blots. Transcriptomic analysis of Dis3l2-depleted RAW 264.7 cells show a striking Type I interferon signature. Treating cells with an EV inhibitor was associated with cellular accumulation of some of the aberrant RNAs found in EVs, as well as upregulation of interferon-stimulated genes.

Conclusion: Our data implicate EVs in a novel RNA surveillance pathway that competes with other surveillance pathways to purge cells of RNAs that may otherwise activate an interferon response. Thus, EVs may be involved in protecting cells from aberrant activation of innate immune sensors. Such pathways may be important for diseases like systemic lupus erythematosus, where aberrant nucleic acid sensing and an interferon response are implicated in pathogenesis. 1. Shurtleff MJ, Yao J, Qin Y, Nottingham RM, Temoche-Diaz MM, Schekman R, et al. Broad role for YBX1 in defining the small noncoding RNA composition of exosomes. Proc Natl Acad Sci U S A. 2017;114(43):E8987-E95.2. Wolin SL, Maquat LE. Cellular RNA surveillance in health and disease. Science. 2019;366(6467):822-7.


Disclosures: S. Williams: None; S. Sim: None; S. Wolin: None.

To cite this abstract in AMA style:

Williams S, Sim S, Wolin S. Aberrant Noncoding RNAs Are Enriched in Extracellular Vesicles and Implicated in Interferon Activation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/aberrant-noncoding-rnas-are-enriched-in-extracellular-vesicles-and-implicated-in-interferon-activation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aberrant-noncoding-rnas-are-enriched-in-extracellular-vesicles-and-implicated-in-interferon-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology